Privia Health Group (PRVA) risk factors, FY2024 10-K

Other

1. 01Our business model relies on a complex legal framework that governs our relationships with Medical Groups and Privia Providers. Legal challenges or shifting interpretations of applicable laws could require us to make significant changes to our operations, which could adversely affect our business
2. 02Our business, financial condition and results of operations may be adversely affected by changes and uncertainty in the healthcare industry, including health reform initiatives and other changes to laws and regulations
3. 03We, our Medical Groups and Privia Providers, may be subject to legal proceedings, including litigation, governmental investigations and claims, and payer audits

Risks Related to our Business and Operations

1. 04Risks associated with VBC arrangements may negatively impact our business, operations, and financial condition
2. 05An increase in the volume of uninsured patients or deterioration in the collectability of patient responsibility accounts could adversely affect our financial condition and results of operations
3. 06The reimbursement process is complex and may involve delays and other uncertainties, which may adversely affect our business, operations, and revenues
4. 07The information that we or our Medical Groups provide to Medicare Advantage plans could be inaccurate, incomplete or unsupportable, which could impact risk adjustment scores and ultimately result in harm to our business, operations and financial condition
5. 08Third-party payer controls designed to reduce costs and other payer practices to decrease or review utilization, surgical procedure volumes or reimbursement for services rendered may reduce our revenues
6. 09If the Company and its Medical Groups are unable to effectively compete, our business, financial condition, and results of operations could be adversely impacted
7. 10Our sales and implementation cycle can be long and unpredictable and requires considerable time and expense, which may cause our results of operations to fluctuate
8. 11Our ability to efficiently price the Privia Technology Solution and our Privia operating model could affect our results of operations and our ability to attract or retain Medical Groups, Privia Physicians, health system or hospital partners, ACO participants and payers
9. 12Our performance depends on our ability to contract with Medical Groups, Privia Providers, health system partners, ACO participants and third-party payers
10. 13The success of our business depends on the execution of our growth strategy, which may not prove viable and we may not realize expected results
11. 14If we fail to manage our growth effectively, we may be unable to execute our business plan, maintain high levels of stakeholder service and patient satisfaction, or adequately address competitive challenges
12. 15If the estimates and assumptions we use to determine the size of our total addressable market, or TAM, are inaccurate, our future growth rate may be impacted and our business could be harmed
13. 16If we are not able to maintain and enhance our reputation and brand recognition, including through the maintenance and protection of trademarks, our business and results of operations will be harmed
14. 17participants, health system or hospital partners, patients, or payers, which could harm our business, results of operations and financial condition
15. 18Changes in treatment methodologies, trends related to the usage of primary care and specialist healthcare services, and other factors outside our control that impact demand for medical services may reduce our revenues
16. 19The failure to obtain medical supplies and drugs for Medical Groups at favorable prices or in sufficient volumes could cause our results of operations to decline

Technology, Cybersecurity and Privacy Risks

1. 20We have, however, experienced limited interruptions in these systems in the past, including temporary slowdowns in the performance of our EMR and platform, and we may experience similar or more significant interruptions in the future
2. 21Our business depends on our ability to effectively invest in, implement improvements to and properly maintain our information technology and other business systems
3. 22If we are unable to protect the confidentiality of our trade secrets, know-how and other proprietary and internally developed information, the value of our technology could be adversely affected
4. 23Any restrictions on our use of, or ability to license, data, or our failure to license data and integrate third-party technologies, could have a material adverse effect on our business, financial condition and results of operations
5. 24Our use of “open source” software could adversely affect our ability to offer our services and subject us to possible litigation
6. 25We face risks associated with healthcare technology initiatives, including those related to sharing patient data and interoperability, as well as our use of certain artificial intelligence and machine learning models
7. 26HIPAA further has certain patient notification requirements for breaches or non-permitted use or disclosure of PHI, which include thresholds for reporting to HHS and local media, and such public reporting may also increase the risk of civil suits related to privacy incidents

Human Capital Risks

1. 27We depend on our senior management team and other key employees, and the loss of one or more of these employees or an inability to attract, recruit, motivate, develop and retain other highly skilled employees could harm our business
2. 28The operations and growth strategy of the Company and its Medical Groups depend on our ability to recruit and retain qualified talent, including physicians and non-physician practitioners
3. 29physicians is limited by the federal Anti-Kickback Statute, the Stark Law, and other applicable laws and regulations intended to prevent fraud and abuse
4. 30Failure to attract and retain talent within our growth and business development teams could impede our growth
5. 31Our management team has limited experience managing a public company
6. 32Our corporate culture has contributed to our success, and if we cannot maintain this culture as we grow, we could lose the innovation, creativity and teamwork fostered by our culture and our business may be harmed

Macroeconomic Risks

1. 33Our overall business results may suffer from an economic downturn
2. 34A deterioration of public health conditions associated with a pandemic, epidemic or outbreak of an infectious disease in the markets in which we operate could adversely impact our business

Financial Risks

1. 35We have a history of net losses, we anticipate increasing expenses in the future, and we may not be able to maintain profitability
2. 36Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations
3. 37We face risks associated with our indebtedness, which could adversely affect our business and growth prospects
4. 38The terms of our Revolving Credit Agreement restrict our current and future operations, particularly our ability to respond to changes or to take certain actions
5. 39Our failure to raise additional capital or generate cash flows necessary to expand our operations and invest in new technologies in the future could reduce our ability to compete successfully and harm our results of operations

General Risks

1. 40Negative publicity relating to our business, industry, Medical Groups or Privia Providers may have a material adverse effect on our financial results
2. 41Increased attention to, and evolving expectations for, environmental, social, and governance (“ESG”) initiatives could increase our costs, harm our reputation, or otherwise adversely impact our business

Risks Related to Our Common Stock

1. 42Provisions of our corporate governance documents could make an acquisition of us more difficult and may prevent attempts by our shareholders to replace or remove our current management, even if beneficial to our shareholders
2. 43Our amended and restated certificate of incorporation designates the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation that may be initiated by our shareholders, which may limit our shareholders’ ability to obtain a favorable judicial forum for disputes with us
3. 44Our operating results and stock price may be volatile, and the market price of our common stock may drop below the price you pay
4. 45Future sales and issuances of our outstanding shares could cause the market price of our common stock to drop significantly, even if our business is doing well
5. 46Because we have no current plans to pay regular cash dividends on our common stock, you may not receive any return on investment unless you sell your common stock for a price greater than that which you paid for it